ASX/CHM (ASX/CHM)

Australian Securities Exchange: ASX/CHM · AUD

A$0.00

+0.00 (0.0%)· Recorded snapshot

Market cap	354.4K
Revenue (ttm)	-189.8K
Net income (ttm)	-18.8M
EPS (ttm)	-A$0.61
Shares out	118.1M
Volume	25,127,056
Beta	0.88

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): -189.8K
Net income (ttm): -18.8M
EPS (ttm): -A$0.61
Market cap: 354.4K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/CHM indicators

Market & fundamental data

Available fields

151

Groups with data

Currency

AUD

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-09-04
Enterprise value	AUD 215,455
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2020
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU0000121576
Last earnings date	2026-02-27
Last refreshed	2026-10-30
Last stock split date	2026-04-22
Last stock split type	Reverse
Market cap	AUD 354,386
Price	AUD 0.00
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-09-30
Symbol	asx/CHM
Website	https://www.chimerictherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-20,323.33%
FCF / EV yield	-5,004.96%
FCF yield	-3,042.85%
Industry forward P/E	29.15x
Sector forward P/E	34.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	4,501.15%
Pretax margin	9,896.16%
ROA	-46.75%
ROA (5Y)	-37.93%
ROCE	112.29%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	AUD 517,452
EBIT	AUD -8.5M
EBITDA	AUD -8M
EPS	AUD -0.61
FCF per share	AUD -0.09
Financing cash flow	AUD 6.1M
Free cash flow	AUD -10.8M
Gross profit	AUD -189,845
Income taxes	AUD 22,140
Investing cash flow	AUD -249,338
Net borrowing	AUD -1.6M
Net cash flow	AUD -5M
Net income	AUD -18.8M
Operating income	AUD -8.5M
Revenue	AUD -189,845

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-132.5
Book value per share	AUD -0.14
Interest coverage	-29.68
Long-term assets	AUD 254,499
Long-term liabilities	AUD 112,867
Net cash (debt)	AUD 138,931
Net cash / market cap	39.2%
Net cash growth	-97.59%
Piotroski F-Score	2
Shareholders' equity	AUD -7.7M
Tangible book value	AUD -8M
Tangible book value per share	AUD -0.15
Total assets	AUD 1.3M
Total cash	AUD 800,145
Total debt	AUD 661,214
Total liabilities	AUD 9M
WACC	25.57%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	AUD 1M
Current liabilities	AUD 8.9M
Current ratio	0.12
Net working capital	AUD -8M
Quick ratio	0.09
Working capital	AUD -7.9M
Working capital turnover	0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-128.2%
Shareholder yield	-128.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.10
1D price change	0%
1M price change	-66.67%
1M total return	-66.67%
1W price change	-40%
1W total return	-40%
1Y price change	-99.25%
1Y return CAGR	-99.25%
1Y total return	-99.25%
20-day SMA	AUD 0.01
200-day SMA	AUD 0.14
3M price change	-95.45%
3M total return	-95.45%
3Y price change	-99.89%
3Y return CAGR	-89.59%
3Y total return	-99.89%
50-day SMA	AUD 0.02
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.40
52-week high date	2025-12-18
52-week low	AUD 0.00
52-week low date	2026-09-30
5Y price change	-99.99%
5Y return CAGR	-84.14%
5Y total return	-99.99%
6M price change	-98.5%
6M total return	-98.5%
All-time high	AUD 44.00
All-time high date	2021-01-21
All-time low	AUD 0.00
All-time low date	2026-09-30
Average true range (ATR)	AUD 0.00
Average volume	3M
Beta (1Y)	0.59
Beta (2Y)	0.2
Beta (5Y)	0.88
Change from 52-week high	-99.25%
Change from 52-week low	0%
Change from all-time high	-99.99%
Change from all-time low	0%
Change from open	-25%
Day's gap	33.33%
Dollar volume	AUD 75,381
High price	AUD 0.00
Low price	AUD 0.00
Monthly RSI	21.96
Open price	AUD 0.00
Position in 52-week range	0%
Previous close	AUD 0.00
Price vs 150-day SMA	-96.98%
Price vs 20-day SMA	-54.55%
Price vs 200-day SMA	-97.87%
Price vs 50-day SMA	-86.05%
Relative volume	8.34
RSI	26.92
Sharpe ratio	-0.99
Sharpe ratio (3Y)	-0.46
Sharpe ratio (5Y)	-0.59
Sortino ratio	-1.5
Sortino ratio (3Y)	-0.67
Sortino ratio (5Y)	-0.86
Volume	25.1M
Weekly RSI	24.48
YTD price change	-98.5%
YTD total return	-98.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97M
Shares change (QoQ)	-10.64%
Shares change (YoY)	128.2%
Shares held by insiders	15.47%
Shares held by institutions	2.06%
Shares outstanding	118.1M

Deeper analysis on ASX/CHM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/CHM report

Is a complete ASX/CHM research report available?

No complete published report is available for asx/CHM (ASX/CHM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/CHM (ASX/CHM)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/CHM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/CHM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/CHM

Frequently asked questions